Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C, Adebrelimab, and Chemotherapy in Metastatic Colorectal Cancer
NCT04516681Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Immune Checkpoint Inhibitors, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid, adebrelimab in colorectal cancer (CRC), sponsored by Fudan University. Started Dec 2024; status: recruiting.
02
Drugs
ascorbic acidadebrelimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04516681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516681.